$DYAI
Dyadic International Inc Stock $dyai

$dyai Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000121380919000028 Filed on May 09, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$390.9K	$402.5K	$184.3K
YoY Change	142.35%	118.37%	53.61%
Cost Of Revenue	$322.2K	$327.9K	$146.8K
YoY Change	149.56%	123.35%	22.34%
Gross Profit	$68.65K	$74.62K	$37.52K
YoY Change	113.39%	98.89%
Gross Profit Margin	17.56%	18.54%	20.36%
Selling, General & Admin	$1.870M	$1.430M	$1.290M
YoY Change	103.26%	10.85%	-27.93%
% of Gross Profit	2724.12%	1916.27%	3438.07%
Research & Development	$818.2K	$692.4K	$576.9K
YoY Change	36.1%	20.02%	80.28%
% of Gross Profit	1191.97%	927.81%	1537.5%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$818.2K	$692.4K	$576.9K
YoY Change	36.1%	20.02%	-75.24%
Operating Profit	-$2.962M	-$2.441M	-$2.230M
YoY Change	63.06%	9.49%	-4.3%
Interest Expense	$265.7K	$267.0K	$186.5K
YoY Change	21.01%	43.18%	24.3%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.700M	-$2.170M	-$2.040M
YoY Change	68.75%	6.37%	-193.58%
Income Tax	$0.00	$900.00	$0.00
% Of Pretax Income
Net Earnings	-$2.696M	-$2.175M	-$2.043M
YoY Change	68.84%	6.46%	-197.3%
Net Earnings / Revenue	-689.68%	-540.4%	-1108.5%
Basic Earnings Per Share
Diluted Earnings Per Share	-$100.6K	-$81.62K	-$72.44K
COMMON SHARES
Basic Shares Outstanding	26.76M shares	26.71M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.89M	$39.75M	$46.79M
YoY Change	-16.78%	-15.05%	8.09%
Cash & Equivalents	$4.782M	$3.976M	$4.631M
Short-Term Investments	$32.10M	$35.78M	$42.16M
Other Short-Term Assets	$200.0K	$290.0K	$780.0K
YoY Change	-74.68%	-62.82%	-89.64%
Inventory
Prepaid Expenses
Receivables	$504.5K	$426.0K	$100.0K
Other Receivables	$410.0K	$830.0K	$470.0K
Total Short-Term Assets	$38.00M	$41.31M	$48.14M
YoY Change	-16.63%	-14.19%	-13.53%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.520M		$500.0K
YoY Change	47.57%
Other Assets	$51.58K	$50.95K	$180.0K
YoY Change	-67.77%	-71.69%	1700.0%
Total Long-Term Assets	$2.069M	$551.6K	$680.0K
YoY Change	73.85%	-18.89%
TOTAL ASSETS
Total Short-Term Assets	$38.00M	$41.31M	$48.14M
Total Long-Term Assets	$2.069M	$551.6K	$680.0K
Total Assets	$40.07M	$41.86M	$48.82M
YoY Change	-14.33%	-14.26%	-12.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$963.3K	$948.1K	$470.0K
YoY Change	318.81%	101.71%	46.88%
Accrued Expenses	$396.0K	$303.0K	$360.0K
YoY Change	108.44%	-15.84%	-12.2%
Deferred Revenue	$90.57K	$23.02K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.450M	$1.274M	$1.000M
YoY Change	208.48%	27.41%	-18.7%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.450M	$1.274M	$1.000M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.450M	$1.270M	$1.000M
YoY Change	208.51%	27.0%	-18.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.91M	-$35.22M
YoY Change
Common Stock	$39.37K	$38.97K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$18.93M	$18.90M
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.62M	$40.59M	$47.83M
YoY Change
Total Liabilities & Shareholders Equity	$40.07M	$41.86M	$48.82M
YoY Change	-14.33%	-14.26%	-12.3%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$2.696M	-$2.175M	-$2.043M
YoY Change	68.84%	6.46%	-197.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.430M	-$1.410M	-$660.8K
YoY Change	-16.86%	113.32%	-11.9%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$2.090M	$3.010M	-$120.0K
YoY Change	574.19%	-2608.33%	-101.59%
Cash From Investing Activities	$2.090M	$3.006M	-$123.0K
YoY Change	574.19%	-2544.04%	-101.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$374.8K
YoY Change		-100.0%	-106.59%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	150.0K	$0.00	-$374.8K
YoY Change		-100.0%	-93.41%
NET CHANGE
Cash From Operating Activities	-1.430M	-$1.410M	-$660.8K
Cash From Investing Activities	2.090M	$3.006M	-$123.0K
Cash From Financing Activities	150.0K	$0.00	-$374.8K
Net Change In Cash	810.0K	$1.589M	-$1.155M
YoY Change	-157.45%	-237.61%	-205.97%
FREE CASH FLOW
Cash From Operating Activities	-$1.430M	-$1.410M	-$660.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001213809
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26763486	shares
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	DYADIC INTERNATIONAL INC
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	49666	USD
CY2019Q1	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	60251	USD
CY2017Q2	dyai	Collaborative Arrangement Duration Of Agreement CollaborativeArrangementDurationOfAgreement	P2Y
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1100000	USD
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1000000	EUR
CY2018Q4	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1
CY2019Q1	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1
CY2018Q1	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-360711	USD
CY2019Q1	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-83112	USD
CY2018Q4	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	41202755	USD
CY2019Q1	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	39753854	USD
CY2018Q4	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	300000	USD
CY2019Q1	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	200000	USD
CY2018Q4	dyai	Prepaid Researchand Developmentin Process Current PrepaidResearchandDevelopmentinProcessCurrent	253446	USD
CY2019Q1	dyai	Prepaid Researchand Developmentin Process Current PrepaidResearchandDevelopmentinProcessCurrent	170334	USD
CY2018Q1	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	392549	USD
CY2019Q1	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	389473	USD
CY2018Q1	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	12336	USD
CY2019Q1	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	12121	USD
CY2018Q1	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	969433	USD
CY2019Q1	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	1081843	USD
CY2018Q1	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	94991	USD
CY2019Q1	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	94762	USD
CY2018Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	240064	USD
CY2019Q1	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	744606	USD
CY2018Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	392549	USD
CY2018Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	400000	USD
CY2017Q4	dyai	Tax Cutsand Jobs Act Change In Alternative Minimum Tax Income Tax Benefit TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit	1001233	USD
CY2017Q4	dyai	Tax Cutsand Jobs Act Changein Tax Rate Deferred Tax Asset Income Tax Expense TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense	400000	USD
CY2018Q1	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	469557	USD
CY2019Q1	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	585487	USD
CY2019Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	389473	USD
CY2019Q1	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	400000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	309060	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	948058	USD
CY2018Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	68996	USD
CY2019Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	122712	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	318744	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	425951	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	399576	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	302970	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	80740	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94385230	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94694793	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	309563	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	269596	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	309563	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3441890	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4541890	shares
CY2018Q4	us-gaap	Assets Assets	43300807	USD
CY2019Q1	us-gaap	Assets Assets	41859526	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	42748052	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	41307959	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85321	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7922	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2386314	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3975761	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2386314	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	3975761	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5786348	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4631312	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2386314	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3975761	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1155036	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1589447	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38966988	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38966988	shares
CY2018Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2043292	USD
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26713486	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26713486	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	38967	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	38967	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	141002	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23024	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	146809	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	327903	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	2414079	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	2843847	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4600000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5000000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3547	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7177	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	268287	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	166168	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4840	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5148	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-4840	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6034	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1292997	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1428067	USD
CY2018Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38816441	USD
CY2019Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	35778093	USD
CY2019Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2174358	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	506866	USD
CY2019Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	500617	USD
CY2018Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	500616	USD
CY2019Q1	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	500616	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-57039	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	641799	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-171841	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	106781	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-102000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-21044	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-3981	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	207572	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-96606	USD
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	166024	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2175258	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2229749	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2441320	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-117978	USD
CY2018Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	USD
CY2019Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6249	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55209	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5049	USD
CY2018Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	186457	USD
CY2019Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	266962	USD
CY2018Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	294240	USD
CY2019Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	290259	USD
CY2018Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	284730	USD
CY2019Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	32201	USD
CY2018Q4	us-gaap	Investments And Cash InvestmentsAndCash	41117434	USD
CY2019Q1	us-gaap	Investments And Cash InvestmentsAndCash	39745932	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43300807	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41859526	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	849638	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1274052	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-374820	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-122999	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3006145	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-660764	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1409521	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-2043292	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	81623	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	76551	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	52139	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	50951	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	91725	USD
CY2019Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	119962	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	374820	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2018Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	17761999	USD
CY2019Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	13190855	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172001	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	166944	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	77249	USD
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Prepaid Insurance PrepaidInsurance	46982	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3027	USD
CY2019Q1	us-gaap	Prepaid Taxes PrepaidTaxes	0	USD
CY2018Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	102000	USD
CY2019Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	6249	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	17639000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	16197000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	576884	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	692370	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33043113	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35218371	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184330	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	402527	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	269596	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	309563	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2936759	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.59
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	989000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1149461	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7320547	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3552890	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4541890	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.57
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.64
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.89
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4860859	USD
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M18D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y0M22D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M10D
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2016Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	USD
CY2016Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2017Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4462339	USD
CY2016Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	15000000	USD
CY2017Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2551717	USD
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	5000000	USD
CY2018Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2158297	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	42451169	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	40585474	USD
CY2016Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.35
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.54
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.58
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.41
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.40
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.52
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2016Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2136752	shares
CY2017Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2363590	shares
CY2017Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	7863980	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	381607	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1644325	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	14390254	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD
CY2016Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2884615	USD
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3639929	USD
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12448283	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	537661	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2304042	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	21814530	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28159244	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26713486	shares
CY2019Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">The Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, and investment securities. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts. </font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0001213809-19-000028-index-headers.html	Edgar Link	pending
0001213809-19-000028-index.html	Edgar Link	pending
0001213809-19-000028.txt	Edgar Link	pending
0001213809-19-000028-xbrl.zip	Edgar Link	pending
dyadiclogoa05.jpg	Edgar Link	pending
dyai-20190331.xml	Edgar Link	completed
dyai-20190331.xsd	Edgar Link	pending
dyai-20190331_cal.xml	Edgar Link	unprocessable
dyai-20190331_def.xml	Edgar Link	unprocessable
dyai-20190331_lab.xml	Edgar Link	unprocessable
dyai-20190331_pre.xml	Edgar Link	unprocessable
exhibit311certifications-m.htm	Edgar Link	pending
exhibit312certifications-p.htm	Edgar Link	pending
exhibit321sectopm1350certi.htm	Edgar Link	pending
exhibit322sectopm1350certi.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q1201910-qdyai.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYAI
Dyadic International Inc Stock $dyai

2019 Q2 Form 10-Q Financial Statement

#000121380919000028 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI Dyadic International Inc Stock $dyai

2019 Q2 Form 10-Q Financial Statement

#000121380919000028 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI
Dyadic International Inc Stock $dyai